Increased expression of ABCA8 in multiple system atrophy brain is associated with changes in pathogenic proteins

Journal of Parkinson's Disease

Volumn 3, Issue 3, 2013, Pages 331-339

  Bleasel, Jonathan M ^a,b   Hsiao, Jen Hsiang T ^a   Halliday, Glenda M ^a,b   Kim, Woojin Scott ^a,b  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

synuclein; ABCA8; Human brain; Multiple system atrophy; Oligodendrocyte; P25

Indexed keywords

ABC TRANSPORTER; ALPHA SYNUCLEIN; ATP BINDING CASSETTE TRANSPORTER A8; MYELIN; PROTEIN P25; PROTEIN P25 ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN REGION; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEUROPATHOLOGY; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; PUTAMEN; VISUAL CORTEX;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; ATP-BINDING CASSETTE TRANSPORTERS; BRAIN CHEMISTRY; CELLS, CULTURED; COMPUTER SYSTEMS; FEMALE; HOMEOSTASIS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; MYELIN SHEATH; NERVE TISSUE PROTEINS; OLIGODENDROGLIA; RNA; TRANSFECTION;

EID: 84888859048     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-130203     Document Type: Article

References (49)

1. Wenning G, Tison F, Ben Shlomo Y, Daniel S, & Quinn N (1997) Multiple system atrophy: A review of 203 pathologically proven cases. Mov Disord, 12, 133-147
2. Ozawa T (2007) Morphological substrate of autonomic failure and neurohormonal dysfunction in multiple system atrophy: Impact on determining phenotype spectrum. Acta Neuropathol, 114, 201-211
3. Wenning G, Shlomo YB, Magalhaes M, Danie S, & Quinn N (1994) Clinical features and natural history of multiple system atrophy. Brain, 117, 835-845
4. Schrag A, Wenning GK, Quinn N, & Ben-Shlomo Y (2008) Survival in multiple system atrophy. Mov Disord, 23, 294-296
5. Papapetropoulos S, Tuchman A, Laufer D, Papatsoris AG, Papapetropoulos N, & Mash DC (2007) Causes of death in multiple system atrophy. J Neurol Neurosurg Psychiatry, 78, 327-329
6. Bower JH, Maraganore DM, McDonnell SK, & Rocca WA (1997) Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990. Neurology, 49, 1284-1288
7. Schrag A, Ben-Shlomo Y, & Quinn N (1999) Prevalence of progressive supranuclear palsy and multiple system atrophy: A cross-sectional study. Lancet, 354, 1771-1775
8. Papp MI, Kahn JE, & Lantos PL (1989) Glial cytoplasmic inclusions in theCNSof patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome). J Neurol Sci, 94, 79-100
9. Fortin DL, Troyer MD, Nakamura K, Kubo S, Anthony MD, & Edwards RH (2004) Lipid rafts mediate the synaptic localization of α-synuclein. J Neurosci, 24, 6715-6723
10. Jo E, McLaurin JA,Yip CM, St George-Hyslop P,&Fraser PE (2000) α-Synuclein membrane interactions and lipid specificity J Biol Chem, 275, 34328-34334
11. Abeliovich A, Schmitz Y, Farinas I, Choi-Lundberg D, Ho WH, Castillo PE, ShinskyN,Verdugo JM, Armanini M, Ryan A, Hynes M, Phillips H, Sulzer D, & Rosenthal A (2000) Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system. Neuron, 25, 239-252
12. Gai WP, Pountney DL, Power JHT, Li QX, Culvenor JG, McLean C, Jensen PH, & Blumbergs PC (2003) α-Synuclein fibrils constitute the central core of oligodendroglial inclusion filaments in multiple system atrophy. Exp Neurol, 181, 68-78
13. Chartier-Harlin MC, Kachergus J, Roumier C, Mouroux V, Douay X, Lincoln S, Levecque C, Larvor L, Andrieux J, & Hulihan M (2004) α-Synuclein locus duplication as a cause of familial Parkinson's disease. Lancet, 364, 1167-1169
14. Zarranz JJ, Alegre J, G'omez-Esteban JC, Lezcano E, Ros R, Ampuero I, Vidal L, Hoenicka J, Rodriguez O, & Atar'es B (2003) The new mutation, E46K, of α-synuclein causes parkinson and Lewy body dementia. Ann Neurol, 55, 164-173
15. Jin H, Ishikawa K, Tsunemi T, Ishiguro T, Amino T, & Mizusawa H (2008) Analyses of copy number and mRNA expression level of the alpha-synuclein gene in multiple system atrophy. J Med Dent Sci, 55, 145-153
16. Ozawa T, Takano H, Onodera O, Kobayashi H, Ikeuchi T, Koide R, Okuizumi K, Shimohata T,Wakabayashi K,&Takahashi H, ST (1999) No mutation in the entire coding region of the alpha-synuclein gene in pathologically confirmed cases of multiple system atrophy. Neurosci Lett, 270, 110-112
17. Morris H, Vaughan J, Datta S, Bandopadhyay R, De Silva HAR, Schrag A, Cairns N, Burn D, Nath U,&Lantos P (2000) Multiple system atrophy/progressive supranuclear palsy: α-synuclein, synphilin, tau, and APOE. Neurology, 55, 1918-1920
18. Al-Chalabi A, Durr A, Wood NW, Parkinson MH, Camuzat A, Hulot JS, Morrison KE, Renton A, Sussmuth SD, Landwehrmeyer BG, Ludolph A, Agid Y, Brice A, Leigh PN, Bensimon G, & Group NGS (2009) Genetic variants of the alpha-synuclein gene SNCA are associated with multiple system atrophy. PLoS ONE, 4, e7114
19. Scholz SW, Houlden H, Schulte C, Sharma M, Li A, Berg D, Melchers A, Paudel R, Gibbs JR, & Simon-Sanchez J (2009) SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol, 65, 610-614
20. Sailer A, on behalf of the MSA GWAS Consortium (2012) First genome-wide association study in multiple system atrophy [abstract]. Mov Disor, 27, 1425
21. Richter-Landsberg C, Gorath M, Trojanowski JQ, & Lee VMY (2000) α-synuclein is developmentally expressed in cultured rat brain oligodendrocytes J Neurosci Res, 62, 9-14
22. Mori F, Tanji K, Yoshimoto M, Takahashi H, &Wakabayashi K (2002) Demonstration of alpha-Synuclein Immunoreactivity in Neuronal and Glial Cytoplasm in Normal Human Brain Tissue Using Proteinase K and Formic Acid Pretreatment. Exp Neurol, 176, 98-104
23. Miller D, Johnson J, Solano S, Hollingsworth Z, Standaert D, & Young A (2005) Absence of α-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia. J Neural Transm, 112, 1613-1624
24. Langerveld AJ, Mihalko D, DeLong C, Walburn J, & Ide CF (2007) Gene expression changes in postmortem tissue from the rostral pons of multiple system atrophy patients. Mov Disord, 22, 766-777
25. Ozawa T, Okuizumi K, Ikeuchi T, Wakabayashi K, Takahashi H, & Tsuji S (2001) Analysis of the expression level of alpha-synucleinmRNAusing postmortem brain samples from pathologically confirmed cases of multiple system atrophy. Acta Neuropathol, 102, 188-190
26. Vogt IR, Lees AJ, Evert BO, Klockgether T, Bonin M, & Wüllner U (2006) Transcriptional changes in multiple system atrophy and Parkinson's disease putamen. Exp Neurol, 199, 465-478
27. Sampathu DM, Giasson BI, Pawlyk AC, Trojanowski JQ, & Lee VM (2003) Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alphasynucleinopathies. Am J Pathol, 163, 91-100
28. Kahle PJ, Neumann M, Ozmen L, Müller V, Jacobsen H, Spooren W, Fuss B, Mallon B, Macklin WB, & Fujiwara H (2002) Hyperphosphorylation and insolubility of α-synuclein in transgenic mouse oligodendrocytes. EMBO Rep, 3, 583-588
29. Stefanova N, Reindl M, Neumann M, Haass C, Poewe W, Kahle PJ, & Wenning GK (2005) Oxidative stress in transgenic mice with oligodendroglial α-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy. Am J Pathol, 166, 869-876
30. Baumann N,&Pham-Dinh D (2001) Biology of oligodendrocyte and myelin in the mammalian central nervous system. Physiol Rev, 81, 871-927
31. Jackman N, Ishii A, & Bansal R (2009) Oligodendrocyte development and myelin biogenesis: Parsing out the roles of glycosphingolipids. Physiology (Bethesda), 24, 290-297
32. Schafer DP, Bansal R, Hedstrom KL, Pfeiffer SE, & Rasband MN (2004) Does paranode formation and maintenance require partitioning of neurofascin 155 into lipid rafts? J Neurosci, 24, 3176-3185
33. Simons M, Krämer EM, Thiele C, Stoffel W, & Trotter J (2000) Assembly of myelin by association of proteolipid protein with cholesterol-And galactosylceramide-rich membrane domains J Cell Biol, 151, 143-154
34. Matsuo A, Akiguchi I, Lee GC, McGeer EG, McGeer PL, & Kimura J (1998) Myelin degeneration in multiple system atrophy detected by unique antibodies. Am J Pathol, 153, 735-744
35. Song YJ, Lundvig DM, Huang Y, Gai WP, Blumbergs PC, Hojrup P, Otzen D, Halliday GM, & Jensen PH (2007) p25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy. Am J Pathol, 171, 1291-1303
36. Skjoerringe T, Lundvig DM, Jensen PH, & Moos T (2006) P25alpha/Tubulin polymerization promoting protein expression by myelinating oligodendrocytes of the developing rat brain. J Neurochem, 99, 333-342
37. Kim WS, Hsiao JH, Bhatia S, Glaros EN, Don AS, Tsuruoka S, Shannon Weickert C, & Halliday GM (2013) ABCA8 stimulates sphingomyelin production in oligodendrocyte. Biochem J, 452, 401-410
38. Benes FM, Turtle M, Khan Y, & Farol P (1994) Myelination of a key relay zone in the hippocampal formation occurs in the human brain during childhood, adolescence, and adulthood. Arch Gen Psychiatry, 51, 477-484
39. Miller DJ, Duka T, Stimpson CD, Schapiro SJ, Baze WB, McArthur MJ, Fobbs AJ, Sousa AMM, Šestan N, & Wildman DE (2012) Prolonged myelination in human neocortical evolution. Proc Natl Acad Sci U S A, 109, 16480-16485
40. Wenning GK, Tison F, Seppi K, Sampaio C, Diem A, Yekhlef F, Ghorayeb I, Ory F, Galitzky M, Scaravilli T, Bozi M, Colosimo C, Gilman S, Shults CW, Quinn NP, Rascol O, & Poewe W (2004) Development and validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Mov Disord, 19, 1391-1402
41. Kovacs GG, Gelpi E, Lehotzky A, Hotberger R, Erdei A, Budka H, & Ovadi J (2007) The brain-specific protein TPPP/p25 in pathological protein deposits of neurodegenerative diseases. Acta Neuropathol, 113, 153-161
42. Lindersson E, Lundvig D, Petersen C, Madsen P, Nyengaard JR, Hojrup P, Moos T, Otzen D, Gai WP, Blumbergs PC, & Jensen PH (2005) p25alpha Stimulates alpha-synuclein aggregation and is co-localized with aggregated alphasynuclein in alpha-synucleinopathies. J Biol Chem, 280, 5703-5715
43. Kov'acs GG, L'aszl'o L, Kov'acs J, Jensen PH, Lindersson E, Botond G, Moln'ar T, Perczel A, Hudecz F, &Mezó G (2004) Natively unfolded tubulin polymerization promoting protein TPPP/p25 is a common marker of alpha-synucleinopathies. Neurobiol Dis, 17, 155-162
44. Hlavanda E, Kov'acs J, Ol'ah J, Orosz F, Medzihradszky KF, &Ov'adi J (2002) Brain-specific p25 protein binds to tubulin and microtubules and induces aberrant microtubule assemblies at substoichiometric concentrations. Biochemistry, 41, 8657-8664
45. Gilman S, Low P, Quinn N, Albanese A, Ben-Shlomo Y, Fowler C, Kaufmann H, Klockgether T, Lang A, & Lantos P (1999) Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci, 163, 94-98
46. Pike LJ (2006) Rafts defined: A report on the keystone symposium on lipid rafts and cell function. J Lipid Res, 47, 1597-1598
47. Erne B, Sansano S, Frank M, & Schaeren-Wiemers N (2002) Rafts in adult peripheral nerve myelin contain major structural myelin proteins and myelin and lymphocyte protein (MAL) and CD59 as specific markers. J Neurochem, 82, 550-562
48. Hanada K, Nishijima M, Akamatsu Y, & Pagano RE (1995) Both sphingolipids and cholesterol participate in the detergent insolubility of alkaline phosphatase, a glycosyl phosphatidylinositol-Anchored protein, in mammalian membranes. J Biol Chem, 270, 6254-6260
49. Scheiffele P, Roth MG, & Simons K (1997) Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain. EMBO J, 16, 5501-5508